Press Releases: Page 2
Post a press release | Manage press releases
-
Report: Precision Medicine M&A is Transforming the Future of the Biotech Industry
Press release from PESG Research • June 15, 2024 -
ProPharma Receives 2024 CRO Leadership Award
Press release from ProPharma • June 13, 2024 -
Industry Update: Dr. Reddy’s Growth Trajectory: Breaking Down the Pharma Giant’s Record Revenues in FY24
Press release from PESG Research • June 12, 2024 -
Octane Medical acquires B. Braun’s global orthobiologics business
Press release from Octane Medical Group • June 07, 2024 -
Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate
Press release from Osteal Therapeutics • June 06, 2024 -
SynapCell and the University of Utah Celebrate their 10 Year Anniversary of Collaboration on Antiseizure Medications
Press release from SynapCell • June 06, 2024 -
Precis Engineering + Architecture Hires Jaime C. Leite, CEM, LEED AP BD+C, as Project Executive
Press release from Precis Engineering + Architecture • June 06, 2024 -
e-therapeutics Announces Pipeline Updates and Final Results for the Year Ended 31 January 2024
Press release from e-therapeutics • June 06, 2024 -
Soterios Pharma Announces Positive Topline Results from Phase II Study of STS-01 in the Treatment of Mild / Moderate Alopecia Areata
Press release from Soterios Pharma • May 30, 2024 -
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab for G/GEJ Cancer at ASCO 2024
Press release from Transcenta • May 28, 2024 -
Validify Launches Risk and Validation Management (RVM) Platform for Regulated Industries
Press release from Validify • May 28, 2024 -
Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market
Press release from Laxxon Medical • May 23, 2024 -
Lord David Prior Appointed as Chair of e-therapeutics' Board of Directors
Press release from e-therapeutics • May 23, 2024 -
Breaking Boundaries in IBD: Evinature's CurQD® Trial Spotlighted at the CCF’s IBD Innovate Conference 2024
Press release from Valuetech • May 09, 2024 -
Dr. Leen Kawas Shares Insights on Her Remarkable Biotechnology Career Journey
Press release from Leen Kawas • May 07, 2024 -
Sapient Appoints Jonathan Usuka as Chief Business Officer
Press release from Sapient • May 07, 2024 -
PumasAI Named Best Clinical Pharmacology Technology Development Firm in Biotechnology Awards
Press release from PumasAI • May 07, 2024 -
Sapio Sciences Unveils Enhanced Molecular Biology Toolkit
Press release from Sapio Sciences • May 07, 2024 -
Ascelia Pharma Successfully Meets Primary Endpoint with Strong Headline Results in Orviglance Phase 3 Study
Press release from Ascelia Pharma • May 02, 2024 -
Aubex Therapeutics Announces Exclusive Licensing Agreement with Georgetown University for Novel Cancer Drug ATX100
Press release from Aubex Therapeutics • May 02, 2024